PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Processa Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.73+0.04 (+2.37%)
Close on Oct 19, 2026
- Market cap
- $4.76M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 18, 2026(first seen in filings) | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Dec 17, 2025 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Mar 29, 2024(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Jan 22, 2024 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Mar 6, 2020(first seen in filings) | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |
| Dec 23, 2019 | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |
| Apr 16, 2018(first seen in filings) | 8-for-3 | Earlier per-share figures divided by 2.6667 |
| Dec 8, 2017 | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |